141 related articles for article (PubMed ID: 9682789)
1. Prevention of osteoporotic hip fracture: global versus high-risk strategies.
Barrett-Connor E; Gore R; Browner WS; Cummings SR
Osteoporos Int; 1998; 8 Suppl 1():S2-7. PubMed ID: 9682789
[No Abstract] [Full Text] [Related]
2. Prevention of hip fractures in older women: a population-based perspective.
Cummings SR
Osteoporos Int; 1998; 8 Suppl 1():S8-12. PubMed ID: 9682790
[TBL] [Abstract][Full Text] [Related]
3. Screening and treatment in the elderly to reduce osteoporotic fracture risk.
Black DM
Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():2-7; discussion 7-8. PubMed ID: 8624337
[No Abstract] [Full Text] [Related]
4. The role of markers of bone turnover in the assessment of fracture risk in postmenopausal women.
Delmas PD
Osteoporos Int; 1998; 8 Suppl 1():S32-6. PubMed ID: 9682795
[No Abstract] [Full Text] [Related]
5. Evidence-based assessment of pharmaceutical interventions.
Melton LJ
Osteoporos Int; 1998; 8 Suppl 1():S17-21. PubMed ID: 9682792
[No Abstract] [Full Text] [Related]
6. Osteoporosis prevention.
Clunie G
Br J Hosp Med; 1994 Jul 13-Aug 16; 52(2-3):79-80, 82-5. PubMed ID: 7952787
[TBL] [Abstract][Full Text] [Related]
7. [Osteoporosis-induced fractures. Bisphosphonates lower risk also in the hip].
MMW Fortschr Med; 2000 Jul; 142(30):52-3. PubMed ID: 10955025
[No Abstract] [Full Text] [Related]
8. Risk factors and prevention of osteoporosis-related fractures.
Dontas IA; Yiannakopoulos CK
J Musculoskelet Neuronal Interact; 2007; 7(3):268-72. PubMed ID: 17947811
[TBL] [Abstract][Full Text] [Related]
9. Risk assessment using bone mineral density determination.
Lindsay R
Osteoporos Int; 1998; 8 Suppl 1():S28-31. PubMed ID: 9682794
[No Abstract] [Full Text] [Related]
10. Targeting high-risk populations.
Jönsson B
Osteoporos Int; 1998; 8 Suppl 1():S13-6. PubMed ID: 9682791
[No Abstract] [Full Text] [Related]
11. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
12. Bone densitometry is not a good predictor of hip fracture.
Dequeker J; Luyten FP
BMJ; 2001 Oct; 323(7316):797-9. PubMed ID: 11642251
[No Abstract] [Full Text] [Related]
13. The role of menopausal hormone therapy in preventing osteoporotic fractures: a critical review of the clinical evidence.
Col NF; Bowlby LA; McGarry K
Minerva Med; 2005 Oct; 96(5):331-42. PubMed ID: 16227948
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
Siris ES; Chen YT; Abbott TA; Barrett-Connor E; Miller PD; Wehren LE; Berger ML
Arch Intern Med; 2004 May; 164(10):1108-12. PubMed ID: 15159268
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of osteoporosis. Risk factors alone are not an indication].
MMW Fortschr Med; 2001 Dec; 143(49-50):57. PubMed ID: 11813710
[No Abstract] [Full Text] [Related]
16. Postmenopausal osteoporosis: act now to prevent fracture.
Lidow IA; Rawlings NL
Adv Nurse Pract; 2005 Sep; 13(9):41-4, 46, 59. PubMed ID: 16152816
[No Abstract] [Full Text] [Related]
17. Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis?
Kanis JA
Osteoporos Int; 1998; 8 Suppl 1():S51-6. PubMed ID: 9682799
[No Abstract] [Full Text] [Related]
18. Inadequate dietary calcium intake in elderly patients with hip fractures.
Lee YH; Lim YW; Ling PS; Tan YY; Cheong M; Lam KS
Singapore Med J; 2007 Dec; 48(12):1117-21. PubMed ID: 18043839
[TBL] [Abstract][Full Text] [Related]
19. [Patients' and population's knowledge of osteoporosis].
Ryg J; Nissen N; Nielsen D; Brixen KT
Ugeskr Laeger; 2005 Jan; 167(3):282-5. PubMed ID: 15704797
[No Abstract] [Full Text] [Related]
20. Thiazide diuretic agents and prevention of hip fracture.
Lacroix AZ
Compr Ther; 1991 Aug; 17(8):30-9. PubMed ID: 1742976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
